PainChek has productive final FDA De Novo clearance meeting
Filed with ASX · · 3 pages · English
Story so far
Earlier from PainChek
- PainChek partners with Eldermark to expand US market reach
- R&D Tax Refund, FDA Review of Adult App & Infant App Launch
- PainChek completes Entitlement Offer raising AUD $5.1 m
- PainChek Implementations, Market and International Expansion
- Prospectus
Later from PainChek
- PainChek Reports Strong Quarterly Sales Growth
- Final US FDA De Novo Clearance Submission Completed
- Strongly Supported A$7.5m Placement to Drive Int. Growth
- Preliminary Final Report
- Compelling Clinical and Economic Results in Scottish Pilot
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek